6
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: not found

      Search for alpha 1-adrenoceptor subtypes selective antagonists: design, synthesis and biological activity of cystazosin, an alpha 1D-adrenoceptor antagonist.

      Bioorganic & Medicinal Chemistry Letters
      Adrenergic alpha-1 Receptor Antagonists, Adrenergic alpha-Antagonists, chemical synthesis, chemistry, pharmacology, Animals, Aorta, Thoracic, drug effects, Binding, Competitive, Drug Design, Humans, In Vitro Techniques, Male, Quinazolines, Quinoxalines, Rats, Receptors, Adrenergic, alpha-1, Receptors, Serotonin, metabolism, Receptors, Serotonin, 5-HT1, Spleen, Structure-Activity Relationship, Vas Deferens

      Read this article at

      ScienceOpenPubMed
      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Two novel quinazolines (2 and 3) related to both prazosin and its open analogue 1 were synthesized, and their biological profile at alpha 1-adrenoceptor subtypes was assessed by functional assays in rat isolated tissues, namely prostatic vas deferens (alpha 1A), spleen (alpha 1B) and aorta (alpha 1D). Furthermore, the binding profile of 3 was assessed at native alpha 2 and D2 receptors, and cloned human 5-HT1A receptors, in comparison to prazosin, (+)-cyclazosin, 1 and BMY 7383. It turned out that the cystamine-bearing quinazoline 3 (cystazosin) has a reversed affinity profile relative to (+)-cyclazosin owing to a higher affinity for alpha 1D-adrenoceptors and a significantly lower affinity for the alpha 1A and alpha 1B subtypes. Furthermore, in comparison to BMY 7378, cystazosin (3) displays a much better specificity profile since it has lower affinity for D2 and 5-HT1A receptors.

          Related collections

          Author and article information

          Comments

          Comment on this article